Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
66,768,263
-
Share change
-
-16,285,353
-
Total reported value
-
$9,038,904,534
-
Put/Call ratio
-
167%
-
Price per share
-
$135.40
-
Number of holders
-
651
-
Value change
-
-$2,204,821,161
-
Number of buys
-
313
-
Number of sells
-
231
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2021
As of 30 Jun 2021,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
651 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,768,263 shares.
The largest 10 holders included
TORONTO DOMINION BANK, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, CITIGROUP INC, JPMORGAN CHASE & CO, MORGAN STANLEY, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, UBS Group AG, and BARCLAYS PLC.
This page lists
656
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.